IL298907A - Administering sulcardin for the treatment of acute atrial fibrillation - Google Patents
Administering sulcardin for the treatment of acute atrial fibrillationInfo
- Publication number
- IL298907A IL298907A IL298907A IL29890722A IL298907A IL 298907 A IL298907 A IL 298907A IL 298907 A IL298907 A IL 298907A IL 29890722 A IL29890722 A IL 29890722A IL 298907 A IL298907 A IL 298907A
- Authority
- IL
- Israel
- Prior art keywords
- sulcardine
- pharmaceutically acceptable
- acceptable salt
- administration
- tmax
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063038664P | 2020-06-12 | 2020-06-12 | |
| PCT/US2021/037098 WO2021252959A1 (en) | 2020-06-12 | 2021-06-11 | Sulcardine administration for treatment of acute atrial fibrillation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL298907A true IL298907A (en) | 2023-02-01 |
Family
ID=78824214
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL298907A IL298907A (en) | 2020-06-12 | 2021-06-11 | Administering sulcardin for the treatment of acute atrial fibrillation |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11813245B2 (https=) |
| EP (1) | EP4164633A4 (https=) |
| JP (1) | JP2023529196A (https=) |
| KR (1) | KR20230024347A (https=) |
| CN (1) | CN116723836A (https=) |
| AU (1) | AU2021288056A1 (https=) |
| BR (1) | BR112022025216A2 (https=) |
| CA (1) | CA3182015A1 (https=) |
| CL (1) | CL2022003501A1 (https=) |
| CO (1) | CO2023000194A2 (https=) |
| IL (1) | IL298907A (https=) |
| MX (1) | MX2022015834A (https=) |
| PH (1) | PH12022553396A1 (https=) |
| WO (1) | WO2021252959A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL298907A (en) * | 2020-06-12 | 2023-02-01 | Huyabio Int Llc | Administering sulcardin for the treatment of acute atrial fibrillation |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1172908C (zh) * | 1999-12-10 | 2004-10-27 | 中国科学院上海药物研究所 | N-取代苄基或苯基芳香磺酰胺化合物及其用途 |
| CN1939298A (zh) | 2005-09-29 | 2007-04-04 | 中国科学院上海药物研究所 | 硫酸舒欣啶固体和靶向制剂及其制备方法 |
| EP2501381B1 (en) * | 2009-11-17 | 2017-07-26 | Huya Bioscience International LLC | Treatment of atrial fibrillation |
| EP2501380B1 (en) * | 2009-11-17 | 2016-01-27 | Huya Bioscience International LLC | Slow infusion of sulcardine and its salts |
| AU2016272089B2 (en) | 2015-06-03 | 2021-02-18 | Triastek, Inc. | Dosage forms and use thereof |
| AU2017261372B2 (en) | 2016-05-05 | 2019-02-14 | Triastek, Inc. | Controlled release dosage form |
| EP3573602A4 (en) | 2017-01-26 | 2020-09-16 | Triastek, Inc. | DOSAGE FORMS OF CONTROLLED RELEASE AT SPECIFIC GASTROINTESTINAL SITES |
| CN113453677A (zh) * | 2018-12-13 | 2021-09-28 | 沪亚生物国际有限责任公司 | 用于治疗急性心房颤动的舒卡定施用 |
| SG11202108160YA (en) * | 2019-01-29 | 2021-08-30 | Huya Bioscience International Llc | Sulcardine salts |
| IL298907A (en) * | 2020-06-12 | 2023-02-01 | Huyabio Int Llc | Administering sulcardin for the treatment of acute atrial fibrillation |
-
2021
- 2021-06-11 IL IL298907A patent/IL298907A/en unknown
- 2021-06-11 CA CA3182015A patent/CA3182015A1/en active Pending
- 2021-06-11 EP EP21823026.6A patent/EP4164633A4/en active Pending
- 2021-06-11 BR BR112022025216A patent/BR112022025216A2/pt unknown
- 2021-06-11 CN CN202180055470.6A patent/CN116723836A/zh active Pending
- 2021-06-11 MX MX2022015834A patent/MX2022015834A/es unknown
- 2021-06-11 KR KR1020237000723A patent/KR20230024347A/ko active Pending
- 2021-06-11 US US17/345,564 patent/US11813245B2/en active Active
- 2021-06-11 PH PH1/2022/553396A patent/PH12022553396A1/en unknown
- 2021-06-11 WO PCT/US2021/037098 patent/WO2021252959A1/en not_active Ceased
- 2021-06-11 AU AU2021288056A patent/AU2021288056A1/en active Pending
- 2021-06-11 JP JP2022575898A patent/JP2023529196A/ja active Pending
-
2022
- 2022-12-09 CL CL2022003501A patent/CL2022003501A1/es unknown
-
2023
- 2023-01-10 CO CONC2023/0000194A patent/CO2023000194A2/es unknown
- 2023-10-11 US US18/484,823 patent/US12465587B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CO2023000194A2 (es) | 2023-03-27 |
| PH12022553396A1 (en) | 2024-04-22 |
| JP2023529196A (ja) | 2023-07-07 |
| MX2022015834A (es) | 2023-04-04 |
| CL2022003501A1 (es) | 2023-06-09 |
| KR20230024347A (ko) | 2023-02-20 |
| WO2021252959A1 (en) | 2021-12-16 |
| US20240058304A1 (en) | 2024-02-22 |
| CA3182015A1 (en) | 2021-12-16 |
| EP4164633A4 (en) | 2024-07-31 |
| EP4164633A1 (en) | 2023-04-19 |
| US12465587B2 (en) | 2025-11-11 |
| US11813245B2 (en) | 2023-11-14 |
| BR112022025216A2 (pt) | 2023-04-04 |
| US20210386708A1 (en) | 2021-12-16 |
| AU2021288056A1 (en) | 2023-02-09 |
| CN116723836A (zh) | 2023-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12357611B2 (en) | Sulcardine administration for treatment of acute atrial fibrillation | |
| IL322175A (en) | Treatment of hypertrophic cardiomyopathy (HCM) with pyrimidinedione compounds | |
| IL266034B2 (en) | Novel polyethylene glycol-modified liposomal apelin formulations for the treatment of cardiovascular diseases | |
| IL322584A (en) | Compositions containing methylphenidate prodrugs, processes for their preparation and use | |
| JP6173391B2 (ja) | サルカルディン及びその塩の緩速点滴 | |
| IL256585A (en) | Topical formulations of diacin or raine and their uses | |
| IL298907A (en) | Administering sulcardin for the treatment of acute atrial fibrillation | |
| IL279208B1 (en) | Therapeutic methods and compositions for treating pancreatic cancer using 6,8-bis(benzylsulfanyl)octanoic acid | |
| JP2013511472A5 (https=) | ||
| JP2012514652A (ja) | 心血管疾患および脂質異常症を治療するための分泌ホスホリパーゼａ２（ｓｐｌａ２）インヒビターとナイアシン薬との組成物および方法 | |
| KR101059330B1 (ko) | 3,７디아자비시클로〔３,３,１〕노난 화합물을 포함하는 액상의 약제학적 제제 및 부정맥발작에 관련한 치료방법 | |
| US20260041665A1 (en) | J-Tp Protection | |
| US20250345312A1 (en) | Formulation and method for treatment of alzheimer's disease, stroke and diabetic retinopathy | |
| EA045624B1 (ru) | Введение сулькардина для лечения острой фибрилляции предсердий | |
| WO2024086819A2 (en) | Diagnosis and treatment of heart failure | |
| IL314334A (en) | Pharmaceutical composition including phthalazinone derivative for co-administration with anticancer drug | |
| HK40061591A (en) | Sulcardine administration for treatment of acute atrial fibrillation | |
| HK1176858B (en) | Slow infusion of sulcardine and its salts |